Name | LDK378 (dihydrochloride) | CAS# | 1380575-43-8 | |
---|---|---|---|---|
Price | ¥Inquiry/1g | Purity | 98.9% | |
Stocking Period |
1 Day | Stock | In Stock |
Detail
Product Information
Ceritinib, also known as LDK-378, is a selective inhibitor of ALK1, a target found in metastatic non-small cell lung cancer (NSCLC). In Phase I trials, LDK378 showed a marked clinical response in 78 patients with anaplastic lymphoma kinase positive (ALK+) metastatic non-small cell lung cancer (NSCLC) who had progressed during or after crizotinib therapy or had not been previously treated with crizotinib. LDK378 blocks the ALK protein and stops it sending growth signals to cancer cells, which may stop them growing. Ceritinib was approved in April 2014. |
Get all suppliers by the below link:
LDK378 (dihydrochloride) suppliers
2024-07-15 |
LDK378 (dihydrochloride)
Price: Inquiry |
2020-12-18 |
LDK-378 dihydrochloride(Ceritinib dihydrochloride)
Price: $450.0 |
2025-09-17 |
LDK378 (dihydrochloride)
Price: ¥Inquiry |
2017-07-23 |
5-chloro-2-N-(5-methyl-4-piperidin-4-yl-2-propan-2-yloxyphenyl)-4-N-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine,dihydrochloride
Price: ¥Inquiry |
2017-12-26 |
LDK378 (dihydrochloride)
Price: ¥Inquiry |
2021-02-06 |
LDK378 dihydrochloride
Price: ¥769.0 |
Get all price from the following link:
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved